Mergers & Acquisitions News 3 October 2025

Strive’s Bitcoin Bonanza: $1.3B Merger, 11K BTC and a Wild Stock Ride

Overview of Strive and Its Role: Strive Asset Management began as an ETF issuer and anti-ESG investment firm (co-founded by Ramaswamy in 2022) etf.com globenewswire.com. In 2025 it transformed into a dedicated

11 October 2025

Protagonist Therapeutics: Small Biotech Skyrockets on Buyout Buzz & Breakthrough Trials

Company Overview Protagonist Therapeutics is a clinical-stage biopharma company leveraging peptide technology to create new medicines for rare hematologic conditions and prevalent immunological diseases protagonist-inc.com. Founded in 2008, Protagonist has built its

11 October 2025

Biotech · Clinical Trials · Mergers & Acquisitions · Pharmaceuticals · Stock Market

Protagonist Therapeutics (PTGX) Skyrockets on J&J Buyout Buzz Amid Clinical Breakthroughs

Recent News and Corporate Developments J&J Buyout Buzz: The biggest news propelling Protagonist’s stock is the report that Johnson & Johnson is in talks to acquire Protagonist reuters.com. On October 10, 2025, The Wall Street

10 October 2025

Biotech Stocks · Clinical Trials · Investment Opportunities · Mergers & Acquisitions · NASDAQ:PTGX · Pharmaceutical Industry

Bristol Myers Snaps Up Orbital Therapeutics in $1.5B Biotech Power Play

In-Depth Analysis BMS’s acquisition of Orbital Therapeutics marks a deliberate push into autoimmune disease treatment via advanced cell therapy. Orbital, founded in 2022 by leaders in RNA and immunology, has built a

10 October 2025

Biotech · Healthcare Industry · Investment · Mergers & Acquisitions · NYSE:BMY · Pharma News

MEDIROM (NASDAQ: MRM) Set for Takeoff: Series A Boost & Altman-Backed ‘Orb’ Deal Fuels 150% Upside

Company Background & Business Model MEDIROM Healthcare Technologies (NASDAQ: MRM) is a Tokyo‑based provider of holistic health and wellness services. Founded in 2000, it operates 300+ Re.Ra.Ku branded relaxation salons across Japan

9 October 2025

Investment · Market Analysis · Mergers & Acquisitions · NASDAQ:MRM · Startups · Stocks

Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Sources: Akero Therapeutics investor materials; Novo Nordisk press statements; Reuters, TS2.tech and FierceBiotechnews reports ts2.tech ts2.tech fiercebiotech.com; MarketBeat and DirectorsTalk analyst surveys marketbeat.com directorstalkinterviews.com; Economic Times deal summary economictimes.indiatimes.com economictimes.indiatimes.com; Business Wire legal alert businesswire.com businesswire.com; and TradingView market data marketbeat.com tradingview.com.

9 October 2025

Biotech News · Investment Insights · Mergers & Acquisitions · NASDAQ:AKRO · NYSE:NVO · Pharma Industry · Stock Market

Confluent, Inc. (CFLT) – Will a Real‑Time Data Pioneer Become a Takeover Target? (October 8 2025)

Confluent (CFLT) Stock Surges on Takeover Rumors – What’s Next for the Data Streaming Pioneer?

Latest News and Developments Confluent’s headquarters in Silicon Valley. The company’s rumored sale exploration has made headlines, spurring a surge in its stock price as investors speculate on a potential acquisition. The

8 October 2025

Data Streaming · Investment Strategies · Mergers & Acquisitions · NASDAQ:CFLT · Stock Market · Technology News

Confluent, Inc. (CFLT) – Will a Real‑Time Data Pioneer Become a Takeover Target? (October 8 2025)

Stock Price & Short‑Term Performance Confluent trades on the NASDAQ under ticker CFLT. According to the company’s historical price lookup, the stock closed at $21.26 on 6 Oct 2025 and dropped to $20.73 on

8 October 2025

Investing · Mergers & Acquisitions · NASDAQ:CFLT · Real-Time Data · Stock Analysis · Technology

Comerica’s Mega Merger Shock: Why CMA Stock Skyrocketed as Fifth Third’s $10.9 Billion Deal Reshaped Regional Banking

Fifth Third’s $10.9 B Comerica Takeover Shakes Up Banking – Will Comerica Park Get a New Name?

A $10.9 B Deal to Create a Top-10 Bank Fifth Third Bancorp, based in Cincinnati, agreed to acquire Comerica Inc. of Dallas in an all-stock transaction valued at $10.9 billion reuters.com. The merger will

6 October 2025

Banking · Business News · Finance · Mergers & Acquisitions · NASDAQ:FITB · NYSE:CMA · Sports Venues

Comerica’s Mega Merger Shock: Why CMA Stock Skyrocketed as Fifth Third’s $10.9 Billion Deal Reshaped Regional Banking

Current Stock Performance & Market Reaction The announcement of Fifth Third Bancorp’s planned acquisition of Comerica sent CMA stock soaring. On 6 October 2025, Comerica’s investor‑relations website showed the stock opening near $81.00 and

6 October 2025

Banking Industry · Financial News · Mergers & Acquisitions · NASDAQ:FITB · NYSE:CMA · Regional Banks · Stock Market

White Mountains Stock Skyrockets on $1.75B Bamboo Deal and Major CEO Shake-Up

White Mountains Stock Rockets +10% on $1.75B Bamboo Deal – What Investors Need to Know

Figure: White Mountains’ share price spiked on Oct. 3, 2025 after announcing the $1.75B Bamboo sale reuters.com investing.com. Stock Surge on Oct. 3, 2025 White Mountains saw one of its biggest single-day

3 October 2025

Financial News · Investing · Mergers & Acquisitions · NYSE:WTM · Stock Market · White Mountains

White Mountains Stock Skyrockets on $1.75B Bamboo Deal and Major CEO Shake-Up

Stock Performance & Market Data Price: As of Oct 3, 2025 (morning), WTM is trading around $1,820 per share markets.financialcontent.com. It opened near $1,785 and hit intraday highs ~$1,863 markets.financialcontent.com. This is

3 October 2025

CEO Changes · Finance · Mergers & Acquisitions · NASDAQ:WTM · Stock Market · Stock News · White Mountains

Mergers & Acquisitions News 3 October 2025 - 11 October 2025